Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comeback From Long coursE ADT With RElugolix and Darolutamide in Hormone-sensitive Prostate Cancer (CLEARED)

NCT06463457 is registered in ClinicalTrials.gov with Atish Choudhury, MD as lead sponsor.

NCT NCT06463457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06463457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comeback From Long coursE ADT With RElugolix and Darolutamide in Hormone-sensitive Prostate Cancer (CLEARED)
Lead sponsor
Atish Choudhury, MD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 13, 2024
Completion date
November 30, 2028
Enrollment
33 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced prostate cancer, hormone sensitive prostate cancer, prostate cancer